-
Tesla sales slip as it loses EV crown to China's BYD in 2025
-
UK sees record-high electricity from renewables in 2025: study
-
Budanov: Enigmatic spy chief set to become Zelensky's top aide
-
Greece and Argentina make winning starts at United Cup
-
Nortje gets nod for South Africa's T20 World Cup campaign
-
Arteta urges Arsenal to break New Year Premier League curse
-
Norway closes in on objective of 100% electric car sales
-
Dani Alves invests in Portuguese third division club
-
Trump says US will 'come to their rescue' if Iran kills protesters
-
Orsted files lawsuit against US suspension of wind turbine leases
-
South Koreans now free to read North's newspaper, once banned as seditious
-
Stocks make bright start to 2026
-
Bashir, Potts in England squad for final Ashes Test
-
Argentina topple Spain for winning United Cup start
-
Champions Narvaez and Ruegg to defend Tour Down Under titles
-
'Are they OK?': desperate search for the missing after Swiss fire
-
'Are they OK?': desparate search for the missing after Swiss fire
-
Asia stocks make bright start to 2026
-
Miami and Houston stretch NBA win streaks to four games
-
Swiss investigators rush to identify victims of New Year's fire
-
Bicycle kick king El Kaabi is new AFCON hero for hosts Morocco
-
What to look out for in the Premier League transfer window
-
Maduro elusive on US attack, open to dialogue
-
Venus Williams gets Australian Open wildcard aged 45
-
Trump blames bruised hand on aspirin, denies falling asleep
-
Dress for success: Mexican president's ideological attire
-
Best of frenemies: Saudi, UAE rivalry bursts into view
-
'Positive signs' on hospitalised Australian cricket great Martyn
-
North Korean leader's daughter in first visit to symbolic mausoleum
-
The Crans-Montana fire: a Swiss tragedy that raises questions
-
Around 40 killed as fire ravages Swiss ski resort New Year party
-
Australia's Khawaja to retire after Ashes finale, slams 'racial stereotyping'
-
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
-
Sound Money Groups Announce Inaugural Journal: Sound Money Review
-
Datavault AI Inc. Bolsters Intellectual Property and Litigation Capabilities with the Addition of Kasowitz LLP lead by Marc Kasowitz to Legal Team
-
Washington State Targets Savers with New Sales Tax on Gold and Silver, Effective January 1st
-
Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language
-
Gladstone Alternative Income Fund Announces Increase in Monthly Cash Distribution for January 2026
-
Ondas Holdings Announces Plan to Change Name to Ondas Inc., Establishes West Palm Beach as Corporate Headquarters
-
Black Book Research Publishes the 2026 State of Global Digital Healthcare Technology
-
IRS Can Pursue Past 1099 Income Years Later - Clear Start Tax Explains How Long Contractors Stay Exposed
-
Metallic Minerals Provides Corporate Update and Responds to Recent Market Activity
-
Investar Holding Corporation Announces Completion of Wichita Falls Bancshares, Inc. Acquisition
-
Golden Minerals Company Substantially Reduces Liabilities in Mexico
-
Tocvan Provides 2025 Year in Review
-
WeTrade Supports UNICEF to Improve Children's Wellbeing in Indonesia
-
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
-
Frank accepts 'boring' jibes from Spurs fans after Brentford stalemate
-
Guardiola vexed by Man City's sloppy finishing in Sunderland draw
-
Tears and stunned silence at vigil for Swiss fire victims
AI tools help choose best embryos for IVF
Artificial intelligence tools can now help choose the most promising embryos for in vitro fertilisation (IVF), although experts have warned of some ethical concerns.
Procedures such as IVF allow millions of children to be born across the world each year to parents who have otherwise struggled to conceive.
However the success rate of the procedure, which involves creating an embryo by fertilising an egg with sperm in the lab, can vary widely and declines with age.
Now, almost 50 years after the first IVF child was born, "artificial intelligence is here to help us select better embryos or at least help determine their potential for implantation", Nathalie Massin, the head of the clinical unit of an IVF centre at the American Hospital of Paris, told AFP.
The facility in the French capital carries out more than 2,300 IVF procedures every year. It is equipped with an embryoscope, which works as a time-lapse camera that continuously films the development of the embryos.
The data recorded by the camera -- such as the shape, symmetry and cell division of the embryo -- had previously only been used to a limited extent.
But tools using AI such as machine learning have been shown to help doctors select the embryos that have the best chance of being successfully implanted or frozen for later.
This would reduce the number of costly IVF attempts for hopeful parents by ruling out the embryos most likely to have abnormalities which lead to miscarriages.
AI tools can do this without manipulating the embryos, so it is not related to concerns about genetically engineered "designer babies".
- 'Avoid the emotional rollercoaster' -
Frida Entezami, co-leader of the IVF department at the American Hospital of Paris, emphasised that "humans will continue to make the decisions but with this additional tool".
The hospital acquired its AI from Israeli start-up AIVF. The tool is currently being tested internally with the aim of "halving the number of cycles needed to achieve pregnancy", Entezami said.
"AIVF will offer a 70-percent probability that the embryo it recommends will not have genetic abnormalities," Entezami said.
That is a "significant improvement" given that currently around half of pre-implantation embryos have such abnormalities, she added.
Tools harnessing AI can also help adjust the timing and dosage of hormone injections before collecting eggs, and increase the chance of finding sperm in a sample with a low number.
Anne-Claire Lepretre, head of the assisted reproductive technologies (ART) unit at France's Biomedicine Agency, told AFP that the algorithms are tested to ensure they are using the correct data.
Because "unfortunately ART does not always work the first time", lots of information from a failed attempt can be fed into AI models to increase the chances of success in the future, she added.
Such "personalised" assistance for hopeful parents could "avoid the emotional rollercoaster" of these "long, complex and often psychologically difficult" journeys, Lepretre said.
- Opt out option for AI sceptics? -
However other researchers have urged caution.
"The use of AI in embryo selection means that computer algorithms are beginning to make decisions about who is brought into the world," said Julian Koplin, a bioethicist at Australia's Monash University who led a recent review of the practice.
"We argue that since some patients may have genuine moral objections to the use of AI to make decisions about which children they have, they should be informed about its use, and should ideally be able to opt out," Koplin said in a statement.
The review, published in the journal Human Reproduction earlier this year, called for more scrutiny but found that the "ethical concerns do not amount to arguments against the use" of AI tools for embryo assessment.
"There is a lot of talk about AI," Michael Grynberg, a French obstetrician-gynaecologist specialising in IVF, told AFP.
"We need more relevant markers because those related to the morphology of an egg or sperm are not sufficient," he added.
D.Moore--AMWN